A Phase Ib Study of Cancer Stem Cell (CSC) Pathway Inhibitor BBI-608 in Combination with Gemcitabine and Nab-Paclitaxel (Nab-Ptx) in Patients (pts) with Metastatic Pancreatic Ductal Adenocarcinoma (Mpdac).
Journal of Clinical Oncology（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要